A human homolog of the yeast Ssk2/Ssk22 MAP kinase kinase kinases, MTK1, mediates stress-induced activation of the p38 and JNK pathways factors (Dérijard et al., 1994; Freshney et al., 1994; Mutsuhiro Takekawa, Francesc Posas and Lee et al., 1994; Rouse Haruo Saito 1 Sluss et al., 1994; Waskiewicz and Cooper, Division of Tumor Immunology, Dana-Farber Cancer Institute and 1995; Zervos et al., 1995; Kyriakis and Avruch, 1996; Department of Biological Chemistry and Molecular Pharmacology, Mertens et al., 1996) Blank et al., 1996; Hirai et al., 1996; Rana et al., 1996 ; inhibited the activation of the p38 pathway by environ- Salmeron et al., 1996; Ichijo et al., 1997), the function of mental stresses (osmotic shock, UV and anisomycin), these MAPKKK candidates is largely unclear. In contrast, but not the p38 activation by the cytokine TNF-α. The the MAP kinase pathways in yeast are much more clearly dominant-negative MTK1(K/R) had no effect on the defined, partly because of the organism's intrinsic simactivation of the JNK pathway or the ERK pathway.
Introduction
similarity exists between the two osmosensors and they seem to function independently of each other. Sho1 has In mammalian cells, a variety of extracellular stimuli four predicted transmembrane segments and a C-terminal generate intracellular signals that converge on a limited cytoplasmic region containing an SH3 domain. Sho1 number of the so-called mitogen-activated protein (MAP) interacts with, and activates, the Pbs2 MAPKK through kinase pathways. The central core of each MAP kinase the Ste11 MAPKKK (Posas and Saito, 1997) . The second pathway is a conserved cascade of three protein kinases, osmosensor, Sln1, is a homolog of prokaryotic twowhich are commonly referred to as MAP kinase (MAPK), component signal transducers and transmits signals to the MAPK kinase (MAPKK) and MAPKK kinase (MAPredundant Ssk2 and Ssk22 MAPKKKs, via the Sln1-KKK) (Marshall, 1994 ). An activated MAPKKK phosYpd1-Ssk1 multi-step phospho-relay system (Maeda et al., phorylates and activates a specific MAPKK, which then 1994 MAPKK, which then , 1995 Posas et al., 1996) . Activated Ssk2 and Ssk22 activates a specific MAPK. While the prototypic MAPKs
MAPKKKs independently phosphorylate and activate the (ERK1 and ERK2) are indeed activated by mitogenic Pbs2 MAPKK (Maeda et al., 1995; Posas and Saito, 1997) . stimulation, the two other types of MAPKs [jun-N-terminal Thus, signals emanating from the two transmembrane kinase (JNK; also known as SAPK) and p38 (also known osmosensors converge at the Pbs2 MAPKK, which then as RK, p40, CSBP, SAPK2, Mix2 and HOG1)] are activates the Hog1 MAPK (Brewster et al., 1993) . Because activated by environmental stresses such as osmotic shock, UV irradiation, heat shock, wound stress and inflammatory a major outcome of the activation of this osmoregulatory MAPK pathway is the elevated synthesis of glycerol, this pathway is referred to as the HOG (high osmolarity glycerol response) pathway (Brewster et al., 1993; Albertyn et al., 1994) . The HOG pathway is essential for the survival of yeast in high osmolarity environments (Boguslawski, 1992; Brewster et al., 1993) .
The HOG osmoregulatory signal transduction pathway is homologous to the mammalian p38 pathway. The MAPKKs in the HOG and p38 pathways (yeast Pbs2 and mammalian MKK3 and MKK6) are very similar, as are the respective MAPKs (yeast Hog1 and mammalian p38) (Boguslawski and Polazzi, 1987; Brewster et al., 1993; Han et al., 1994; Dérijard et al., 1995) . Moreover, the (Han et al., 1994) .
(Clontech) was probed with a 32 P-labeled MTK1 cDNA corresponding to nucleotides 1557-3605. Positions of molecular size standards are
The similarity between the yeast HOG pathway and the indicated on the right in kilobases (kb). mammalian p38 pathway suggests the existence of a mammalian homolog of the Ssk2/Ssk22 MAPKKKs, that would activate the Pbs2 MAPKK. In this paper, we report four Osm R transformants contained an apparently identical plasmid with a 1.8 kb insert. Nucleotide sequence deterthe functional cloning of the mammalian Ssk2/Ssk22 homolog which we named MTK1 and the role of MTK1 mination of the representative clone, pNV7-7H1 ( Figure  2 ), indicated that it encodes a protein kinase domain that in the mammalian stress signal transduction.
is very similar to the catalytic domains of Ssk2 and Ssk22. We also obtained three Osm R cells from the 1.9ϫ10 6
Results transformants generated using a Jurkat (human T lymphoma) cDNA library. Two of these contained an
Cloning of a human homolog of the yeast Ssk2/Ssk22 MAPKKKs by functional apparently identical plasmid represented by pNV7-7J1, which contains a 3.8 kb insert that overlaps with the complementation The ssk2Δ ssk22Δ sho1Δ triple mutant yeast cells do not pNV7-7H1 cDNA insert (Figure 2 ). The other Osm R transformant contained a plasmid that is similar to pNV7-grow on high osmolarity media, because they cannot activate the Pbs2 MAPKK and the Hog1 MAPK, and 7J1 but with a longer 3Ј non-coding sequence (not shown). The protein kinase encoded by these cDNA clones was consequently cannot initiate proper adaptive responses (Figure 1) . Expression of any one of the functional SSK2, named MTK1 (MAP Three Kinase 1). Northern blot analysis of various human tissues demon-SSK22 and SHO1 genes is sufficient to suppress the osmosensitivity of the triple mutants (Maeda et al., 1995) . strated that an~6 kb MTK1 mRNA is expressed at high levels in heart, placenta, skeletal muscle and pancreas, In order to isolate a human homolog of either the SSK2, SSK22 or SHO1 gene, the yeast strain MY007 (ssk2Δ and at lower levels in other tissues (Figure 3 ). Because the 7H1 and 7J1 cDNA inserts are significantly shorter ssk22Δ sho1Δ) was transformed with human cDNA libraries made in the yeast expression vector pNV7
than the estimated size of the MTK1 mRNA, we isolated additional MTK1 cDNA clones by DNA-DNA hybridiz- (Ninomiya-Tsuji et al., 1991) and osmoresistant (Osm R ) transformants were selected. Four Osm R yeast cells were ation. One MTK1 cDNA clone (L23) was isolated from a fetal liver library and three additional clones (M1, M24 identified among the 2ϫ10 6 transformants generated with a HeLa (human cervical carcinoma) cDNA library. All and M32) were obtained from an adult skeletal muscle Gerwins et al., 1997; Shiozaki et al., 1997) . MEKK4 is probably the mouse homolog of the human MTK1. Roman numerals above the sequences refer to subdomains conserved across the protein kinase family (Hanks and Quinn, 1991) . cDNA library (Figure 2 ). The combined length of the MTK1 cDNA sequences, 5445 nucleotides excluding the poly(A) tail, accounts for most of the estimated size of the MTK1 mRNA, and contains an open reading frame encoding a protein of 1607 amino acids ( Figure 4A ). The MTK1 protein kinase catalytic domain is located in the C-terminal 266 amino acids (1342-1607) and is most closely related to the MAPKKK family (Figures 4B and 5) . Indeed, the human MTK1 appears to be the homolog of the mouse MEKK4, which has 98% identity with MTK1 in the kinase domain (Gerwins et al., 1997) . In addition to MEKK4, high degrees of identity were found with Ssk2 (42% identify), Ssk22 (36%) and the Schizosaccharomyces pombe Wik1 (41%) in the kinase domain ( Figures 4B and 5 ). Wik1 is an S.pombe homolog of the Ssk2/Ssk22 MAPKKKs and mediates the signals generated by high osmolarity and other environmental stresses (Shiozaki et al., 1997) . The structural similarity of Ssk2, Ssk22 and Wik1 to MTK1 is not limited to their kinase domains. When the Sp, S.pombe; Hu, human; Mu, mouse; and Mm, mammals. database using the BLAST program, these three kinases (in addition to MEKK4) were the only proteins that had statistically significant similarity (P Ͻ0.001). The similarity is scattered throughout the N-terminal nonkinase domain. Figure 4C shows a stretch of MTK1 (260-306) that has particularly high similarity to the corresponding sequences in Ssk2, Ssk22 and Wik1 ( Figure  4C ). Although a region in mouse MEKK4 (225-398) was proposed to be a pleckstrin homology (PH) domain (Gerwins et al., 1997), we did not find any similarity between MTK1 and PH domain proteins.
A variant form of mouse MEKK4 exists that lacks a 52-amino acid sequence, probably a product of alternative splicing (Gerwins et al., 1997) . In MTK1, this sequence corresponds to amino acids 1175-1223 (underlined in Figure 4A ). The three MTK1 cDNA clones we isolated that spanned this region (7H1, 7J1 and M32) contained the corresponding 49 amino acids. However, sequencing analyses of RT-PCR products derived from HeLa and Jurkat mRNA preparations indicated that a shorter form of MTK1 mRNA that lacks the 49 codons also exists in these cells (data not shown).
MTK1 can functionally replace the Ssk2 and Ssk22 MAPKKKs in the yeast HOG MAP kinase pathway
To gain insight into the role of MTK1 in human cells, we initially investigated the mechanism by which MTK1 suppresses the osmosensitivity of ssk2Δ ssk22Δ sho1Δ mutant yeast. Expression of the MTK1 cDNA sequences, either 7J1 or 7H1, suppressed the osmosensitivity of the triple mutant, but not the osmosensitivity of pbs2Δ or hog1Δ mutants ( Figure 6A ). These results suggest that the suppressive action of MTK1 occurs upstream of the Pbs2 and Hog1 kinases, in yeast. To confirm further that MTK1 acts upstream of Pbs2 and Hog1, we generated a constitutively active MTK1 mutant, MTK1ΔN, which contains only the kinase domain (Val1333 to the (Maeda et al., 1995) . If MTK1 acts upstream of Pbs2, the with either an empty expression vector (pYES2) or plasmids containing MTK1 cDNA fragments, pNV7-7J1 (7J1) or pNV7-7H1
It was possible that MTK1 conferred osmoresistance to the ssk2Δ ssk22Δ sho1Δ triple mutant cells by activating the Ste11 MAPKKK (see Figure 1 ). However, MTK1 cDNA clones could also suppress the osmosensitivity of that MTK1 suppresses the osmosensitivity by directly activating the Pbs2 MAPKK. Thus, MTK1 can functionthe FP50 (ssk2Δ ssk22Δ ste11Δ) triple mutant cells, demonstrating that the suppression by MTK1 does not ally replace the Ssk2 and Ssk22 MAPKKKs in the yeast HOG osmoregulatory MAP kinase pathway. The structural require Ste11 MAPKKK (data not shown). Because Ssk2, Ssk22 and Ste11 are the only known kinases that activate similarity between MTK1 and Ssk2/Ssk22 is also consistent with this conclusion. the Pbs2 MAPKK (Posas and Saito, 1997) , it is concluded signal transduction of both the p38 and JNK pathways, but not the ERK pathway.
MTK1 phosphorylates and activates MKK3, MKK6 and SEK1, both in vivo and in vitro
While the overexpression of MTK1 leads to the activation of p38 and JNK1 MAPKs, the direct substrates of MTK1 are likely to be members of the MAPKK family. Therefore, we tested whether MTK1 stimulates the activities of any of the following four MAPKKs: MKK3, MKK6, SEK1 and MEK1. Together, these four MAPKKs represent the three major MAP kinase pathways (i.e. p38, JNK and ERK pathways) (Marshall, 1994; Waskiewicz and Cooper, 1995; Kyriakis and Avruch, 1996) . In the following experiments, COS-7 cells were co-transfected with various amounts of full-length MTK1 vector together with one of the GST-tagged MAPKK constructs (GST-MKK3, GST- phosphorylation of the activation sites of MKK3, MKK6 and SEK1, precipitated GST-MAPKKs were probed with antibodies specific to their phosphorylated forms. Figure   MTK1 activates both the p38 and JNK pathways, but not the ERK pathway, in vivo 8 (middle row) shows that MTK1 co-transfection indeed results in increased levels of phosphorylated MKK3, To study the role of MTK1 in mammalian cells, we determined whether any of the known MAP kinase path-MKK6 and SEK1 (MEK1 was not tested, because there was no increase in its catalytic activity). These results, ways are activated by MTK1. Initially, COS-7 cells were transiently transfected with full-length MTK1 together therefore, suggest that MTK1 directly phosphorylates and activates MKK3, MKK6 and SEK1. However, the with one of the three HA-tagged MAPK constructs (HAp38, HA-JNK1 and HA-ERK2). The HA-tagged MAPKs alternative possibility that MTK1 activates another kinase that phosphorylates the MAPKKs cannot be excluded by were immunoprecipitated from cell extracts and their kinase activities were measured in vitro using specific these experiments alone.
To test directly whether MTK1 can phosphorylate and substrates [GST-ATF2, GST-jun and myelin basic protein (MBP) respectively]. As shown in Figure 7 (left panel), activate MAPKKs, an in vitro kinase assay was performed using purified enzymes and substrates. The kinase domain the activities of p38 and JNK1 kinases, but not ERK2 kinase, were stimulated by co-transfection of MTK1.
of wild-type MTK1 or a catalytic-site mutant MTK1(K/R) were fused to the GST domain [GST-MTK1ΔN and Consistent detection of the activated p38 required the inclusion of deoxycholate in the lysis buffer, suggesting GST-MTK1(K/R)ΔN respectively], expressed in yeast and purified using glutathione-Sepharose beads. In the first that the majority of the activated p38 is translocated to nuclei. In this and following experiments, the amount of series of in vitro experiments, we tested if the recombinant MTK1 kinase can phosphorylate various MAPKKs (Figure tagged protein in the various immunoprecipitates was determined by immunoblotting and found to be the same 9A). For this purpose, we prepared GST-tagged MAPKKs that are catalytically inactive [GST-MKK6(K/A), GSTfor each set of experiments.
To compare, more quantitatively, the capacity of MTK1 SEK1(K/R) and GST-MEK1(K/M)]. Because of the catalytic site mutations, these recombinant MAPKKs have no to activate various MAP kinase pathways, HeLa cells were transfected with increasing amounts of MTK1 vector kinase activities and will not autophosphorylate. When purified GST-MAPKKs were used as substrates in the together with a constant amount of the epitope-tagged MAPK constructs (either Flag-p38, HA-JNK1 or HAin vitro kinase assay, GST-MTK1ΔN phosphorylated both GST-MKK6(K/A) and GST-SEK1(K/R), but not GST-ERK2). The activities of the tagged MAPK were then assayed in vitro. MTK1 activated both p38 and JNK1 MEK1(K/M). As anticipated, the catalytic site mutant GST-MTK1(K/R)ΔN did not phosphorylate any substrate equally well and, consistent with the results from COS-7 cells, MTK1 did not stimulate the ERK2 kinase in HeLa in these assays. We then tested if the in vitro phosphorylation of MKK6 and SEK1 is functionally relevant using cells (Figure 7, right panel) . Therefore, MTK1 mediates Fig. 8 . MTK1 overexpression activates MKK3, MKK6 and SEK1, but not MEK1, in vivo. COS-7 cells were transiently transfected with 1 μg per plate of a mammalian expression vector encoding GST-MKK3, GST-MKK6, GST-SEK1 or GST-MEK1, together with various concentrations of the pcDNAI-MTK1 expression vector. The total amount of DNA was kept constant by adding appropriate amounts of the empty vector pcDNAI-Amp. After 48 h, GST-tagged MAPKKs were purified using glutathione-Sepharose beads and the activity of individual GST-tagged MAPKK was assessed by an in vitro kinase assay using GST-p38(K/N) (for MKK3, MKK6 and SEK1) or GST-ERK1(K/N) (for MEK1) as substrates (upper panel). Phosphorylation of the precipitated GST-tagged MAPKK was analyzed by immunoblotting using antibodies specific to phosphorylated MKK3/6 or SEK1 (middle panel). The expression level of each GST-MAPKK in total cell lysates was monitored by anti-GST blot (lower panel). a coupled kinase assay ( Figure 9B ). In this kinase assay, the catalytically active version of the GST-MAPKKs was pre-incubated with GST-MTK1ΔN [or the control GST-MTK1(K/R)ΔN] in the presence of non-radioactive ATP. Subsequently the kinase activities of the GST-MAPKKs were assayed in the presence of [γ-32 P]ATP and specific substrates [catalytically inactive MAPKs: GST-p38(K/N) for MKK6 and SEK1; GST-ERK1(K/N) for MEK1]. As shown in Figure 9B , both MKK6 and SEK1 were catalytically active after they were pre-incubated with GST-MTK1ΔN, but not with GST-MTK1(K/R)ΔN. Taken together, the in vitro kinase studies indicate that recombinant MTK1 kinase can specifically phosphorylate and activate both MKK6 and SEK1. The inability of MTK1 to phosphorylate MEK1 is consistent with our in vivo results.
Inhibition of the activation of the p38 pathway by a dominant-negative MTK1 mutant
To define further the role of MTK1 in mammalian signal transduction, the effect of overexpressing a kinase-inactive MTK1 mutant [MKT1(K/R)] on the activation of the MAP kinase pathways was studied. Because MTK1(K/R) does not have any detectable kinase activity ( Figure  9 ), overexpression of MTK1(K/R) might inhibit signal transduction pathways in which MTK1 is intimately Figure 10A ). In contrast, the osmotic shock-induced JNK activity was not affected by overexpression of either MTK1(K/R) or MTK1(K/R)ΔN MTK1(K/R). As summarized in Figure 11 , expression of MTK1(K/R) inhibited the stimulation of the p38 pathway ( Figure 10B ). The activation of ERK2 by phorbol 12-myristate 13-acetate (PMA) treatment (100 nM for 20 by sorbitol, anisomycin and UV-C irradiation. In contrast, the stimulation of the p38 pathway by TNF-α was not min) was also unaffected by the co-expression of either MTK1(K/R) or MTK1(K/R)ΔN ( Figure 10C ).
affected by MTK1(K/R). The activation of the JNK pathway, either by sorbitol, anisomycin, UV-C irradiation We then examined whether the activation of the p38 pathway by other stress stimuli is also inhibited by or TNF-α, was not inhibited by MTK1(K/R). Thus, the dominant inhibitory effect of MTK1(K/R) appears specific only to the stress-induced activation of the p38 pathway.
Discussion
We isolated the human homolog of the yeast Ssk2 and Ssk22 MAPKKKs by functional complementation in yeast. The seven cDNA clones isolated in two independent screenings using the ssk2Δ ssk22Δ sho1Δ host cells all encoded MTK1, and in a similar screening using ssk2Δ ssk22Δ ste11Δ host cells, only MTK1 clones were obtained. Thus, although the two human cDNA libraries contain clones of other MAPKKKs, none were selected, demonstrating that our screening procedure was highly specific for the functional homolog of the Ssk2 and Ssk22 MAPKKKs. The identification of MTK1 as an activator of MKK3 and MKK6 completes the parallel between the yeast HOG pathway and the mammalian p38 pathway (see Figure 1 ). An interesting observation was that the homology between MTK1 and Ssk2/Ssk22 was also found in their N-terminal non-catalytic domains. The similarity between the N-terminal regions of the yeast and mammalian MAPKKKs may indicate a common regulatory mechanism. The deletion of the N-terminal sequences from Ssk2, the N-terminal domain might be a reflection of a common After 48 h, cells were treated with sorbitol (0.3 M for 20 min), activation mechanism. The N-terminal region of Ssk2 anisomycin (10 μg/ml for 30 min), UV-C (80 J/m 2 followed by a 1 h and Ssk22 interacts with the two-component regulator incubation at 37°C), TNF-α (100 ng/ml for 15 min) or without any stimulus (none). The kinase activity of immunoprecipitated molecule Ssk1, which is an activator of the Ssk2/Ssk22 epitope-tagged p38 or JNK1 was measured by an in vitro kinase assay MAPKKKs (Maeda et al., 1995) . Because both the yeast as described in Figure 10 . Data represent the averages and standard HOG pathway and the mammalian p38 pathway are deviations of three independent determinations, expressed as fold activated by osmotic stress, it is possible that they share increase with respect to empty vector-transfected cells without any a common upstream activation mechanism. Although the stimulation.
presence of two-component regulators in mammalian cells has not been demonstrated, similar molecules were identified in diverse eukaryotes (Wurgler-Murphy and Both the p38 and JNK MAP kinase pathways are activated by a variety of extracellular stresses (osmotic . Obviously, it is also possible that the mammalian and yeast cells use completely different osmosensing shock, the protein synthesis inhibitor anisomycin, UV-C irradiation, etc.) as well as cytokines such as TNF-α, mechanisms (Rosette and Karin, 1996) .
IL-1 and TGF-β. Although MTK1 can activate, when and is also a minor mediator for the JNK pathway. The N-terminal non-kinase domain may contain a regulatory overexpressed, both the p38 and JNK pathways, the dominant-inhibitory effect of MTK1(K/R) was observed domain whose function is analogous to the corresponding region of Ssk2 and Ssk22. only for the p38 pathway. Furthermore, MTK1(K/R) inhibited the p38 pathway only when it was activated by extracellular stresses: if the p38 pathway was activated
Materials and methods
by TNF-α, the overexpression of MTK1(K/R) had no significant inhibitory effect. Signaling from the TNF-α
Yeast strains
The following yeast strains were used: MY007 (MATa ura3 leu2 his3 receptor is believed to be mediated by small GTPases (Coso et al., 1995; Minden ura3 leu2 his3 pbs2::LEU2) . et al., 1995) . However, in our preliminary experiments, Buffers co-expression of MTK1(K/R) did not inhibit the activation Buffer A is 50 mM Tris-HCl (pH 7.5), 10 mM MgCl 2 and 2 mM of JNK by either Cdc42 Q61L or Rac1 Q61L (data not shown).
dithiothreitol. Lysis buffer is 20 mM Tris-HCl (pH7.5), 1% Triton Together with our observation that the overexpression of X-100, 10% glycerol, 137 mM NaCl, 2 mM EDTA, 50 mM MTK1(K/R) does not inhibit the TNF-α-induced activation β-glycerophosphate, 1 mM sodium vanadate, 1 mM dithiothreitol, 1 mM PMSF, 10 μg/ml leupeptin and 10 μg/ml aprotinin. Kinase buffer is of the p38 and JNK pathways, we tentatively conclude 25 mM Tris-HCl (pH 7.5), 20 mM MgCl 2 , 0.5 mM sodium vanadate that the activation of MTK1 is not mediated by the and 2 mM dithiothreitol. SDS loading buffer is 50 mM Tris-HCl cytokine-Cdc42-Rac1 pathway.
(pH 6.8), 100 mM DTT, 2% SDS, 0.1% Bromophenol Blue and While our data alone do not prove any specific mechan- by MTK1 alone (or mainly by MTK1). If so, then MTK1(K/R) expression will have a severe inhibitory Cloning by DNA-DNA hybridization and sequence analysis Lambda phage cDNA libraries made from human fetal liver or skeletal effect on the stress activation of the p38 pathway, as we muscle mRNA were screened using the 5Ј-terminal XhoI-BamHI fragobserved. The cytokine activation of the p38 pathway is ment derived from the pNV7-7J1 insert as a hybridization probe, as probably mediated by MAPKKK(s) distinct from MTK1, described previously (Streuli et al., 1987) . The cDNA inserts in positive because MTK1(K/R) had no effect on the TNF-α induction clones were subcloned into the EcoRI site of the pBluescript vector. In all cases, both strands of DNA were sequenced by the dideoxyribonucleotide of the p38 activity. Figure 1 schematically shows a possible method using modified T7 DNA polymerase (Tabor and Richardson, role for MTK1 in the p38 and JNK MAP kinase pathways. component activator that is homologous to yeast Ssk1.
MEKK4, which is a putative mouse homolog of the 2 micron) is based on the high-copy number yeast vector pRS426 of the catalytically inactive GST-MAPKKs, purified from E.coli, were incubated with 1.25 μg of purified GST-MTK1ΔN or GST-MTK1(K/ (Christianson et al., 1992) and contains the GST domain under the control of the yeast GAL1 promoter. p426GAG-MTK1ΔN was constructed by R)ΔN in buffer A containing 50 μM [γ-32 P]ATP (0.2 μCi/μl). After 10 min incubation at 30°C, reactions were stopped by the addition of subcloning a DNA segment of MTK1 (Val1333 to the C-terminus) between the unique BamHI and EcoRI sites in p426GAG.
2ϫ SDS loading buffer. Labeled proteins were resolved by SDS-PAGE and detected by autoradiography. Tissue culture and transient transfection COS-7 and HeLa cells were maintained in Dulbecco's modified Eagle's
In vitro activation of MAPK kinases by MTK1 medium (DMEM) supplemented with 10% fetal bovine serum,
In vitro activation of MAPKKs was monitored by a coupled kinase L-glutamine, penicillin and streptomycin. For transient transfection assay. Three quarters of a microgram of the recombinant GST-MAPKKs, assays, cells grown in 35 mm dishes were transfected with the appropriate purified from E.coli, were incubated with 1.25 μg of purified MTK1ΔN combinations of expression plasmids using lipofectamine (GIBCO BRL), or MTK1ΔN(K/M) in buffer A containing 50 μM ATP. After 10 min according to the manufacturer's protocol. Total amount of plasmid DNA incubation at 30°C, 2.5 μg of catalytically inactive MAPK subwas adjusted to 2 μg per plate with vector DNA (pcDNAI-Amp) and strate, purified from E.coli, was added in the presence of [γ-32 P]ATP transfected COS-7 cells were cultured overnight in serum-free medium.
(0.2 μCi/μl). The mixture was incubated for an additional 5 min at 30°C The cells were harvested 48 h after transfection and where indicated and the reactions were stopped by addition of 2ϫ SDS loading buffer. the cells were treated with sorbitol (300 mM for 20 min), anisomycin GST-p38(K/N) was used as a substrate for MKK6 and SEK1 whereas (10 μg/ml for 30 min), UV-C (80 J/m 2 followed by a 1 h incubation at GST-ERK1(K/N) was used to measure the activation of MEK1. Labeled 37°C), TNF-α (100 ng/ml for 15 min) or phorbol 12-myristate 13-proteins were resolved by SDS-PAGE and detected by autoradiography. acetate (100 nM for 20 min).
Immunoprecipitation and protein kinase assays

